COMPANY INTELLIGENCE PROFILE
Docmode Health Technologies Limited (also styled "DocMode Health Technologies Limited")
DocMode is a healthcare ed-tech / vocational-training company for medical professionals.
Docmode Health Technologies Limited, listed on the NSE SME platform since February 2024, is a Mumbai-based healthcare ed-tech company focusing on medical professional training. Founded in 2017, it offers certified Continuing Medical Education programs alongside AI-driven tools for clinical support. As of FY2025, the company reported ₹41.71 crore in revenue and a net loss of ₹2.03 crore. A 2024 IPO raised ₹6.71 crore. The company is led by CEO Hans Lewis and Managing Director Paresh Sampat.
AI-generated, may contain errors.
Business Overview
- DocMode is a healthcare ed-tech / vocational-training company for medical professionals.
- Core platform docmode.org delivers certified Continuing Medical Education (CME) — video lectures, courses, conferences and workshops — across specialties, cardiology, infectious diseases, ophthalmology, dermatology, women's health, etc., partnering with medical associations, FOGSI, IDA, ICOG, CSI.
- Product suite per Stockanalysis.com: DocMode.org (LMS), Gapsule, pharma–practitioner info hub, DocMode SURE, clinical research participation, DocMode KNOW, knowledge marketing, DocMode CARE, clinical applications, DocMode SHOP, medical books/journals.
- Newer offering "AIDE" is described as an AI/GenAI clinical decision-support and knowledge tool for doctors.
- Founded 2017, HQ Mumbai, ~58 employees.
- Founder/CEO: Hans Lewis (per LinkedIn)
- Managing Director per corporate filings: Paresh Sampat. [Sources: docmode.org, stockanalysis.com, LinkedIn]
Sector & Classification
"Other professional, scientific and technical activities" / Professional & technical services (broad Tofler classification "Business Services"); precise 5-digit NIC code not obtained.
Directors & Key Management
Directors — source notes
From TheCompanyCheck (confirmed director names also independently listed by Tofler, without DINs): - Paresh Jaysih Sampat — DIN 00410185 (Managing Director) - Monina Elizabeth Lewis — DIN 10147743 (Director) - Nilay Shivnarayan Sharma — DIN 00231299 (Director) - Hans Albert Lewis — DIN 02301853 (CFO/Director; LinkedIn lists him as Founder & CEO — designation conflict between sources) - Paulson Paul Thazhathedath — DIN 02301881 (Whole-Time Director; also an IPO promoter) - Sujit Nityanand Chakraborty — DIN 07275025 (Director) Promoters at IPO: Paulson Paul Thazhathedath and Hans Albert Lewis [ipoji.com]. DINs sourced from a single site (TheCompanyCheck) — treat as partial confidence pending a second DIN-bearing source (Falconebiz DIN pages were inaccessible in this session).
GST Registrations
Not obtained. PAN (AAGCD2655R) is known, but GSTIN lookup tools (findgst.in, knowyourgst.com, mastersindia.co) required direct interactive form submission that could not be completed via fetch — no PAN→GSTIN or state-registration-count data could be retrieved this session. Do not infer or fabricate a GSTIN.
Financials
Docmode Health Technologies Limited showcased strong revenue growth from ₹7.10 crore in FY21 to ₹41.71 crore in FY25. However, profitability declined significantly with a PAT loss of ₹2.03 crore in FY25, as flagged by Tofler. Net worth stood at ₹8.35 crore despite reduced borrowings.
AI-generated, may contain errors.
- Standalone figures, Screener.in, sourced from exchange filings, figures in ₹ Crore:
- | Metric | FY2023, Mar-23, pre-IPO, | FY2024 (Mar-24) | FY2025, Mar-25, latest audited, |
- |---|---|---|---|
- | Revenue | 32.97 | 39.93 | 41.71 |
- | EBITDA/Operating Profit | — | 1.88 | -0.69, screener shows a conflicting +0.25 EBITDA read on one fetch — flagged conflict, |
- | PAT | 1.95 | 0.19 | -2.03 (loss) |
- | Net Worth | 3.48 | 10.38 | 8.35 |
- | Total Borrowings | 8.48 | 9.18 | 6.82 |
- FY21/FY22 pre-IPO, from IPO prospectus via ipoji.com: Revenue ₹7.10 Cr (FY21) → ₹12.44 Cr (FY22) → ₹32.97 Cr (FY23)
- PAT ₹0.55 Cr → ₹0.92 Cr → ₹1.95 Cr.
- No separate consolidated financials found, company appears to have no subsidiaries as of latest filing.
- Bottom line: strong topline growth through FY24-25 but profitability reversed sharply in FY25, EBITDA and PAT turned negative, — flagged by Tofler as "profitability challenges."
Funding History
- Company funded itself primarily via its Feb 2024 NSE SME IPO, ₹6.71 Cr raised, 8,49,600 shares at ₹79.
- No pre-IPO institutional/VC funding rounds were found in the sources checked this session, Tracxn page returned HTTP 429 and could not be read — Tracxn should only be used for round names per instructions, and none could be confirmed.
- Treat pre-IPO funding history as not obtained.
Loans & Charges
- One registered charge found (Tofler): Charge holder — Orbis Trusteeship Services Private Limited
- Amount — ₹1.0 Cr
- Created/modified — 7 May 2024
- Status — appears open/not shown as satisfied. Only one charge on record per Tofler
- Not cross-verified on a second source.
Credit Ratings
- None found. No CRISIL/ICRA/CARE rating could be located for this company in the sources checked, CARE Ratings search page returned a 404 in this session
- As a small NSE-SME-listed company it may not carry a formal bank-facility credit rating. Status: none found.
Legal & Compliance
- No litigation/case records found on Indian Kanoon for "Docmode Health Technologies", search returned zero matches. Status: none found, absence of hits, not exhaustive proof of no litigation.
Competitive Landscape
- Indicative healthcare ed-tech / medical-CME peers in India, based on sector knowledge, not individually source-verified this session — treat as directional, not confirmed:
- 1. Medvarsity Online Ltd, Apollo-linked medical e-learning platform, — larger, more established scale.
- 2. Docplexus — doctor community/CME and pharma-engagement platform — comparable/slightly larger scale.
- 3. M3 India, arm of Japan's M3 Inc., — much larger, global-backed medical information/CME platform.
- 4. Curofy — doctor networking/education app — comparable-to-smaller scale.
- 5. Univadis India (MSD) / Medscape (global) — much larger, pharma-major-backed medical content platforms, indirect competitors.
- Given the small scale, ~₹40 Cr revenue, 58 employees, Docmode sits at the smaller/niche end of this competitive set.
Frequently Asked Questions
What does Docmode Health Technologies Limited do?
Docmode Health Technologies Limited is a healthcare ed-tech company offering vocational training and certified Continuing Medical Education (CME) for medical professionals across various specialties through its platform docmode.org.
What is the CIN of Docmode Health Technologies Limited?
The Corporate Identification Number (CIN) of Docmode Health Technologies Limited is U74999MH2017PLC297413.
When was Docmode Health Technologies Limited incorporated?
Docmode Health Technologies Limited was incorporated on 17 July 2017.
Where is the registered office of Docmode Health Technologies Limited located?
The registered office of Docmode Health Technologies Limited is located at 201, Kalpataru Plaza, Rambaug, Off Chincholi Bunder Road, Malad West, Mumbai City, Maharashtra, 400064.
Sources
Tofler (tofler.in) — identity, capital, directors, financials, charges; TheCompanyCheck (thecompanycheck.com) — identity, PAN, directors+DINs, listing status; Screener.in (screener.in/company/DHTL) — FY24/FY25 standalone financials and shareholding pattern; Stockanalysis.com (stockanalysis.com/quote/nse/DHTL) — business description, employees, CEO/CFO, listing exchange; ipoji.com — IPO terms, promoters, pre/post-IPO shareholding, FY21–23 financials; docmode.org (official site) — business overview, logo image; Indian Kanoon (indiankanoon.org) — litigation search (no hits); CARE Ratings site — attempted, 404; Tracxn — attempted, 429/blocked; findgst.in, knowyourgst.com, mastersindia.co — attempted for GSTIN, no retrievable data; Falconebiz — attempted for DIN cross-check, page structure didn't expose data via fetch; Chittorgarh, Moneycontrol — attempted, blocked (403/fetch restriction).
Information compiled from public registry and secondary sources. It may be incomplete or dated; verify independently before relying on it.